Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis

Published:2018-04 Issue:4 Volume:29 Page:803-811
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Trone J.C.,Ollier E.,Chapelle C.,Bertoletti L.,Cucherat M.,Mismetti P.,Magné N.,Laporte S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/4/803/24702707/mdy035.pdf

Reference42 articles.

1. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

2. Angiogenesis inhibitors as therapeutic agents in cancer: challenges and future directions;Lin;Eur J Pharmacol,2016

3. Antiangiogenic therapy in oncology: current status and future directions;Jayson;Lancet,2016

4. Vascular toxicities of cancer therapies: the old and the new–an evolving avenue;Herrmann;Circulation,2016

5. Biotherapies in metastatic colorectal cancers in 2014;Jouinot;Presse Med,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arterial Thrombosis in Patients with Cancer;Cancers;2024-06-17

2. A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia;Advances in Therapy;2024-06-04

3. Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer »;La Revue de Médecine Interne;2024-04

5. Anticoagulant treatment of cancer-associated thromboembolism;Archives of Cardiovascular Diseases;2024-01